[1] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[2] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[3] |
AN Yanxiao, JIAO Hanliang, QI Yanwei, ZHONG Zhiyong.
Effects of lncRNA PSMA3-AS1 on proliferation,migration and invasion of neuroblastoma cells by regulating the miR-186?5p/SOX4 axis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 715-721.
|
[4] |
WANG Xingchen, LIAO Dawen, LI Jiaying, SUN Xiacheng, BI Qian, Huang Qichao, HUANG Jiangtao.
Comparative analysis of molecular characteristics of constitutive activation of NRAS and CTNNB1 in liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 577-585.
|
[5] |
LIANG Yuanzheng, WANG Henan, WANG Liang.
Effects of PPP2R5C on proliferation, apoptosis, and drug sensitivity of multiple myeloma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 405-411.
|
[6] |
TANG Min, HUANG Juanchan, WEI Xingwen, LUO Xuewen, ZHAO Wei .
Effects of disulfiram combined with Cu2+ induced cuproptosis on proli-feration,migration and invasion of hepatoma Hep3B cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 417-423.
|
[7] |
LU Feichen, YOU Xuemei, ZHAO Fengjuan, LI Fanrong, WEI Shuangshuang, YANG Lijie.
Investigation on the status quo of the quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 468-473.
|
[8] |
CHEN Shunqi, LIU Xinyi, ZENG Tao, LIU Mengyu, WANG Yuting, XIN Haibei, LI Yuanfeng, ZHOU Gangqiao#br#.
TM6SF1 affects the biological behavior of intrahepatic cholangiocarcinoma cells by inhibiting the KRAS-MEK-ERK signaling pathway
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 261-270.
|
[9] |
LI Huadao, LIN Liqiao, LIANG Yubing, HUANG Enhao, PAN Linghui.
Effects of Herba Houttuyniae on the biological behavior of liver cancer cells and a network pharmacology analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 277-284.
|
[10] |
YAN Haiqing, LAI Qinqiao, WU Liucheng, WANG Ting'an, XIA Xiang, HUANG Mingwei, QIN Yuzhou.
Effects of SH3BGRL on proliferation and migration of gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 285-294.
|
[11] |
LU Yubo, FANG Yanle, WEI Jianxin, GAO Yuguang, LANG Xing, LI Jingtao, MA Xinsheng.
Effects of artesunate on proliferation,apoptosis and autophagy of nephroblastoma cells by regulating AMPK/mTOR/ULK1 signaling pathway
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 295-301.
|
[12] |
WANG Juwei, WANG Jing, MA Lijun, LI Zan .
Trends in the incidence and mortality of liver cancer in China based on the JoinPoint regression model,2000—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 180-185.
|
[13] |
HE Ziyun, WANG Haolun, FAN Qianqing, LIU Zhihui .
Effects of manganese ion on proliferation and apoptosis of liver cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 62-66.
|
[14] |
HUANG Hao, LIANG Jingjing, TAO Yifeng, PAN Xiaolan, FANG Min.
Analysis of hepatitis B virus serum markers in 92,031 cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 101-106.
|
[15] |
DONG Jiaqi, FANG Tao, OU Yong, WEI Jingyi, HU Longquan, LI Yuanyuan, CHAO Xu.
Vitexicarpin inhibits the proliferation of liver cancer cells by regulating glucose metabolism reprogramming
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 615-622.
|